Project Grant HT94252311023
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$488K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...
Trustees of Indiana University was awarded a $7.8 million project grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop pharmacotherapies for the treatment of hydrocephalus and associated conditions from September 1, 2023 through August 31, 2027. Under this award, Indiana University will leverage its expertise in biomedical research to investigate medical solutions targeted toward the military health system....
This Project Grant award, with a total funding of $158,500.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports an investigation into redox signaling as a potential therapeutic target for malignant peripheral nerve sheath tumors (MPNST). The ultimate period of performance for this grant is from July 1, 2024 to June 30, 2026. The grant recipient is the Trustees of Indiana University, doing business as Indiana...
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
This Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a $749,378 investigation into the systemic administration of STO-609 to prevent post-traumatic osteoarthritis in a translational porcine intraarticular fracture model. The principal investigator and awardee is the Trustees of Indiana University, which will conduct this research from August 1, 2025 through July 31, 2028. As a prominent public research...
The Defense Health Agency awarded a $622,008 project grant to the Trustees of Indiana University, doing business as Indiana University, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on November 1, 2024, with a completion date of October 31, 2026, supports research on "The SAGA Complex as an Essential Regulator of Abnormal Transcription Through De Novo DNA Topology Interactions in Multiple Myeloma." This project grant aims to...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,999,924 Project Grant to the Trustees of Indiana University to support a 3-year research project titled "EARLY IMMUNOLOGIC PRECISION TYPING AT-RISK FRACTURES TO PREDICT NONUNION". The project aims to characterize the temporal immune/inflammatory biomarker profile in patients with open tibial fractures and develop a predictive model to guide decision-making for musculoskeletal...